Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Anthem, Inc.    ANTM

ANTHEM, INC.

(ANTM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

ANTHEM INC : Ex-dividend day for

share with twitter share with LinkedIn share with facebook
share via e-mail
09/09/2019 EST

A dividend is removed today from Anthem Inc's share.



© Factset 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on ANTHEM, INC.
02/25ANTHEM : Announces Appearance at Upcoming Conference
BU
02/24Health insurer shares pummeled by Sanders surge, virus worries
RE
02/19ANTHEM : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
AQ
02/10ANTHEM : Health Care Company Anthem Joins NC State's IBM Q Hub
AQ
02/04CENTENE : Profit Dented by Higher Costs
DJ
01/29ANTHEM : Falls on Weak Metric, Disappointing 2020 Guidance -- Update
DJ
01/29ANTHEM : Falls on Weak Metric, Disappointing 2020 Guidance
DJ
01/29ANTHEM : Insurer Anthem underwhelms Wall Street with 2020 forecast
AQ
01/29ANTHEM : Raises Quarterly Dividend by 19% to 95 Cents
DJ
01/29ANTHEM : Sets 2020 Outlook
DJ
More news
Financials (USD)
Sales 2020 117 B
EBIT 2020 8 439 M
Net income 2020 5 504 M
Debt 2020 14 634 M
Yield 2020 1,47%
P/E ratio 2020 12,0x
P/E ratio 2021 10,4x
EV / Sales2020 0,68x
EV / Sales2021 0,60x
Capitalization 65 066 M
Chart ANTHEM, INC.
Duration : Period :
Anthem, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ANTHEM, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 25
Average target price 346,40  $
Last Close Price 257,86  $
Spread / Highest target 52,0%
Spread / Average Target 34,3%
Spread / Lowest Target 16,3%
EPS Revisions
Managers
NameTitle
Gail Koziara Boudreaux President, Chief Executive Officer & Director
Elizabeth E. Tallett Independent Chairman
John E. Gallina Chief Financial Officer & Executive Vice President
Ramiro G. Peru Independent Director
Julie Anne Hill Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ANTHEM, INC.-11.22%67 662
UNITEDHEALTH GROUP-10.54%249 475
CIGNA CORPORATION-7.61%70 379
HUMANA-10.33%43 419
CENTENE CORPORATION-13.49%31 914
WELLCARE HEALTH PLANS5.97%17 611